Could Psychedelic Drugs Relieve Cancer Pain?
Roswell Park’s Palliative Care team explores surprising new ways to tackle both the physical and psychological sources of cancer pain.
Clinical Scorecard: Could Psychedelic Drugs Relieve Cancer Pain?
At a Glance
| Category | Detail |
|---|
| Condition | Cancer Pain |
| Key Mechanisms | Psilocybin interacts with serotonin receptors, acts as an anti-inflammatory, and alleviates anxiety and stress related to pain. |
| Target Population | Cancer patients experiencing pain and psychological distress. |
| Care Setting | Palliative Care |
Key Highlights
- Approximately 50% of cancer patients experience pain from the disease or treatment.
- Psilocybin may provide relief by addressing both physical and psychological pain.
- The upcoming clinical trial will explore micro-dosing of psilocybin.
- Meaning-based therapy will be integrated into the treatment approach.
- Psychedelics are being researched for their potential to alleviate existential and psychological aspects of pain.
Guideline-Based Recommendations
Diagnosis
- Assess pain levels and psychological distress in cancer patients.
Management
- Consider the use of psilocybin and meaning-based therapy in treatment plans.
Monitoring & Follow-up
- Evaluate changes in pain perception and psychological well-being during treatment.
Risks
- Monitor for potential psychological challenges during high-dose psilocybin administration.
Patient & Prescribing Data
Cancer patients enrolled in clinical trials for pain management.
Micro-dosing of psilocybin may reduce opioid requirements and improve overall well-being.
Clinical Best Practices
- Utilize an interdisciplinary team for comprehensive patient care.
- Incorporate psychological support alongside pharmacological treatments.
- Evaluate the safety and efficacy of psychedelic treatments in controlled settings.
References
